WORLD India's COVID-19 tally crosses 11-mln mark

WORLD

India's COVID-19 tally crosses 11-mln mark

Xinhua

13:02, February 22, 2021

Travellers register themselves with a health worker before getting swab testings for COVID-19 outside a bus station, in Bangalore, India, Feb. 17, 2021. (Str/Xinhua)

NEW DELHI, Feb. 22 (Xinhua) -- India's COVID-19 tally crossed the 11-million mark, reaching 11,005,850 on Monday as 14,199 new cases were registered during the past 24 hours, said the latest data from the federal health ministry.

According to the official data, the death toll mounted to 156,385 as 83 COVID-19 patients died since Sunday morning.

There are still 150,055 active cases in the country, while 10,699,410 people have been discharged so far from hospitals after medical treatment.

There was an increase of 4,421 active cases during the previous 24 hours. The number of active cases in India have been on the rise for the past five consecutive days.

India's nationwide vaccination drive was kicked off on Jan. 16, and over 11 million people, mainly health workers, have been vaccinated across the country.

Meanwhile, the federal government has ramped up COVID-19 testing facilities across the country, and nearly 211 million tests have been conducted so far.

As many as 211,551,746 tests were conducted till Sunday, out of which 620,216 tests were conducted on Sunday alone, said the latest data issued by the Indian Council of Medical Research (ICMR) on Monday.

The national capital Delhi, one of the most COVID-19 affected places in the country, has been witnessing comparatively fewer cases over past several months. As many as 145 new cases and two deaths were registered in the national capital through Sunday.

So far as many as 10,900 people have died in the national capital due to COVID-19, confirmed Delhi's health department.

Two types of vaccines are being administered to the people in India. While the Covishield vaccine, made by the Serum Institute of India (SII), was supplied to all states, the Covaxin vaccine by the Bharat Biotech International Limited was supplied to some states.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue